SCHEMBL6074673

SCHEMBL6074673

CCOC(=O)[C@@H](Cc1ccccc1)[C@](N)(OS(C)(=O)=O)C(=O)OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 2/20 0.44
CTRB1 P17538 1/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
PKM P14618 1/20 0.39
ALDH1A1 P00352 3/20 0.38
EPHX2 P34913 1/20 0.38
PPARG P37231 1/20 0.38
TP53 P04637 1/20 0.38
RECQL P46063 1/20 0.38
NPY1R P25929 1/20 0.38
NPY2R P49146 1/20 0.38
HPRT1 P00492 1/20 0.38
CA12 O43570 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6075140 1.00 MMP8 (0.44) MMP8CTRB1MAPTHTTSMN1; SMN2
SCHEMBL5653528 0.82 MMP8 (0.52) MMP8CTRB1MAPTHTTSMN1; SMN2
SCHEMBL5650006 0.82 MMP8 (0.52) MMP8CTRB1MAPTHTTSMN1; SMN2
SCHEMBL5651688 0.74 MMP8 (0.51) MMP8MAPTSMN1; SMN2HSD17B10MEN1
SCHEMBL5651363 0.74 MMP8 (0.51) MMP8MAPTSMN1; SMN2HSD17B10MEN1
SCHEMBL15930101 0.72 MMP8 (0.55) MMP8MAPTSMN1; SMN2HSD17B10MEN1
SCHEMBL14770008 0.72 MMP8 (0.55) MMP8MAPTSMN1; SMN2HSD17B10MEN1
SCHEMBL6708542 0.72 MMP8 (0.49) MMP8SMN1; SMN2HSD17B10MEN1KMT2A
SCHEMBL304717 0.70 MMP8 (0.49) MMP8MAPTSMN1; SMN2HSD17B10MEN1
SCHEMBL5728110 0.70 MMP8 (0.49) MMP8MAPTSMN1; SMN2HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060135784-A1 PROCESS FOR PRODUCING 3-AMINO-2-HYDROXYPROPIONIC ACID DERIVATIVES KANEKA CORPORATION 2006-06-22 US disclosed
US-7057066-B2 Process for producing 3-amino-2-hydroxypropionic acid derivatives KANEKA CORPORATION (JP) 2006-06-06 US disclosed
EP-1300391-A1 PROCESS FOR PRODUCING 3-AMINO-2-HYDROXYPROPIONIC ACID DERIVATIVES KANEKA CORPORATION (JP) 2003-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135784-A1 PROCESS FOR PRODUCING 3-AMINO-2-HYDROXYPROPIONIC ACID DERIVATIVES AASDHPPT, HPD, HAAO MMP8 4700/4885CTRB1 3478/4885MAPT 1941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.